Muhammad Hanafi
- Drug Discovery top 5%
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities 24
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis 16
- Toxicology top 5%
-
- Natural Antidiabetic Agents Studies 25
-
- Medicinal Plant Research 22
- Natural Compound Pharmacology Studies 19
- Phytochemistry and Biological Activities 15
-
- Synthesis and biological activity 14
-
- Natural product bioactivities and synthesis 14
Muhammad Hanafi
145 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 108
- Drug Discovery 4
- Biochemistry 120
- Pharmacology 136
- Toxicology 50
- Complementary and alternative medicine 117
Countries citing papers authored by Muhammad Hanafi
This map shows the geographic impact of Muhammad Hanafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Hanafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Hanafi more than expected).
Fields of papers citing papers by Muhammad Hanafi
This network shows the impact of papers produced by Muhammad Hanafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Hanafi. The network helps show where Muhammad Hanafi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Muhammad Hanafi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 0 | |
| 4 | 2022 | 0 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 15 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 15 | |
| 14 | 2019 | 5 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 1 | |
| 17 | LIGNAN DERIVATIVES POTENTIAL AS PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE INHIBITORS: MOLECULAR DOCKING APPROACH OF ANTIPLASMODIAL DRUG DESIGN | 2015 | 1 |
| 18 | Identification of Compounds in Water Extract of Bangle Rhizome (Zingiber cassumunar Roxb.) | 2013 | 1 |
| 19 | ISOLASI SENYAWA GLUCOMANNAN DALAM TANAMAN UMBI SINGKONG, WALUR, DAN GADUNG INDIGINOUS INDONESIA | 2012 | 1 |
| 20 | STUDY ON THE SYNTHESIS OF MONOLAURIN AS ANTIBACTERIAL AGENT AGAINTS Staphylococcus aureus Kajian Awal Sintesis Monolaurin sebagai Antibakteri Staphylococcus aureus | 2008 | 1 |
About Muhammad Hanafi
Muhammad Hanafi is a scholar working on Drug Discovery, Biochemistry and Complementary and alternative medicine, having authored 155 papers that have together received 1.2k indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (25 papers), Phytochemicals and Antioxidant Activities (24 papers), Medicinal Plant Research (22 papers), Natural Compound Pharmacology Studies (19 papers), Microbial Natural Products and Biosynthesis (16 papers), Phytochemistry and Biological Activities (15 papers), Synthesis and biological activity (14 papers) and Natural product bioactivities and synthesis (14 papers). The work is most often cited by research in Drug Discovery (4 citations), Biochemistry (120 citations) and Pharmacology (136 citations). Muhammad Hanafi has collaborated with scholars based in Indonesia, Japan and Malaysia. Frequent co-authors include Kozo Shibata, Berna Elya, M. Ueki, Makoto Taniguchi, Nina Artanti, Puspa Dewi Lotulung, Azwar Manaf, Ahmad Royani, Sofa Fajriah and Rizna Triana Dewi. Their work appears in journals such as The Journal of Antibiotics, International Journal of Applied Pharmaceutics, Scientific Reports, Journal of Asian Natural Products Research and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.